BIOENZ TECHNOLOGIES LIMITED

BioEnz Technologies Limited is a cutting‑edge biotechnology company that turns enzyme challenges into breakthrough innovation. Leveraging a patented enzyme‑discovery platform and a unique, proprietary microbial biobank of more than 4,500 characterised microorganisms, BioEnz delivers next‑generation, custom‑designed enzymes that boost efficiency, yield and product purity across a range of industrial processes.

The firm’s core services include accelerated (up to ten‑fold) enzyme discovery, bespoke enzyme development and rapid response to specific process hurdles. Its expertise spans key sectors such as biofuels, where it enhances conversion efficiency and reduces waste; food and beverage production, improving safety, flavour stability and overall process performance; sustainable agriculture, optimising resource use and crop outcomes; and therapeutic applications, providing targeted enzyme solutions for advanced disease treatment.

Backed by a team of seasoned scientists and industry veterans—including CEO Tim Roche and Dr Lee Coffey, a recognised leader in enzyme discovery—BioEnz combines over three decades of collective experience with a 20‑year research legacy to provide agile, reliable solutions that keep partners ahead in a fast‑evolving market.